Manufacturer copay assistance · Kanjinti (Q5117) · Amgen
Eligible patients may… · Covers Kanjinti drug cost only — administration billed separately; benefit resets annually
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Kanjinti — check the full fund board.
Run a benefits estimate for Kanjinti — the program's cap applies against the patient share CareCost calculates.
Yes — Amgen SupportPlus Co-Pay Card Program (Kanjinti) from Amgen. Eligible patients may pay as little as $0 per dose — applies to deductible, co-insurance, and co-payment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay as little as $0 per dose — applies to deductible, co-insurance, and co-payment Maximum benefit: not published. Covers Kanjinti drug cost only — administration billed separately; benefit resets annually
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.